Drugmaker Valeant CEO leaving as investor Ackman joins board
(Reuters) - Drugmaker Valeant Pharmaceuticals International Inc said on Monday its chief executive ******r is leaving and billionaire investor William Ackman would join the board as it tries to clean up accounting problems and save its business. The Canadian company, whose operations include prescription *****, consumer products, and Bausch & Lomb eye care, has lost nearly 90 percent of its value as it came under public scrutiny for its pricing and distribution pra